Vipond C - Search Results

1

Evaluation of a candidate International Standard for Meningococcal Group C polysaccharide.

Vipond C, Mulloy B, Rigsby P, Burkin K, Bolgiano B; MenC IS Working Group. Vipond C, et al. Biologicals. 2012 Sep;40(5):353-63. doi: 10.1016/j.biologicals.2012.03.003. Epub 2012 May 22. Biologicals. 2012. PMID: 22622331

2

Evaluation of candidate international standards for meningococcal serogroups A and X polysaccharide.

Vipond C, Swann CJ, Dougall TW, Rigsby P, Gao F, Beresford NJ, Bolgiano B; MenA/MenX Is Working Group. Vipond C, et al. Biologicals. 2017 May;47:33-45. doi: 10.1016/j.biologicals.2017.03.001. Epub 2017 Apr 5. Biologicals. 2017. PMID: 28389172 Free article.

3

Evaluation of candidate International Standards for meningococcal capsular polysaccharide groups W and Y.

Chan H, Beresford N, Rudd TR, Rigsby P, Vipond C, Gao F, Matejtschuk P, Malik K, Duru C, Atkinson E, Burkin K, De Benedetto G, Lockyer K, Bolgiano B; MenW/MenY IS Working Group. Chan H, et al. Among authors: vipond c. Biologicals. 2024 Aug;87:101780. doi: 10.1016/j.biologicals.2024.101780. Epub 2024 Jul 5. Biologicals. 2024. PMID: 38970883 Free article.

4

Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98/254.

Vipond C, Suker J, Jones C, Tang C, Feavers IM, Wheeler JX. Vipond C, et al. Proteomics. 2006 Jun;6(11):3400-13. doi: 10.1002/pmic.200500821. Proteomics. 2006. PMID: 16645985

5

Characterization of the protein content of a meningococcal outer membrane vesicle vaccine by polyacrylamide gel electrophoresis and mass spectrometry.

Vipond C, Wheeler JX, Jones C, Feavers IM, Suker J. Vipond C, et al. Hum Vaccin. 2005 Mar-Apr;1(2):80-4. doi: 10.4161/hv.1.2.1651. Epub 2005 Mar 2. Hum Vaccin. 2005. PMID: 17038831

6

Characterization of meningococcal serogroup B outer membrane vesicle vaccines from strain 44/76 after growth in different media.

Tsolakos N, Lie K, Bolstad K, Maslen S, Kristiansen PA, Høiby EA, Wallington A, Vipond C, Skehel M, Tang CM, Feavers IM, Wedege E, Wheeler JX. Tsolakos N, et al. Among authors: vipond c. Vaccine. 2010 Apr 19;28(18):3211-8. doi: 10.1016/j.vaccine.2010.02.023. Epub 2010 Feb 25. Vaccine. 2010. PMID: 20188677

7

History of meningococcal vaccines and their serological correlates of protection.

Vipond C, Care R, Feavers IM. Vipond C, et al. Vaccine. 2012 May 30;30 Suppl 2:B10-7. doi: 10.1016/j.vaccine.2011.12.060. Vaccine. 2012. PMID: 22607894 Review.

8

Development and validation of a monocyte activation test for the control/safety testing of an OMV-based meningococcal B vaccine.

Vipond C, Sutherland J, Nordgren K, Kemp G, Heath A, Care R, Studholme L. Vipond C, et al. Vaccine. 2019 Jun 27;37(29):3747-3753. doi: 10.1016/j.vaccine.2018.06.038. Epub 2018 Dec 10. Vaccine. 2019. PMID: 31202503 Free article.

9

Evaluation of the monocyte activation test for the safety testing of meningococcal B vaccine Bexsero: A collaborative study.

Studholme L, Sutherland J, Desai T, Hockley J, Care R, Nordgren IK, Vipond C; Collaborative Study Group. Studholme L, et al. Among authors: vipond c. Vaccine. 2019 Jun 27;37(29):3761-3769. doi: 10.1016/j.vaccine.2018.05.073. Epub 2018 Dec 10. Vaccine. 2019. PMID: 31202504 Free article.

10

Exploring the proteome of meningococcal outer membrane vesicle vaccines.

Wheeler JX, Vipond C, Feavers IM. Wheeler JX, et al. Among authors: vipond c. Proteomics Clin Appl. 2007 Sep;1(9):1198-210. doi: 10.1002/prca.200700204. Epub 2007 Aug 17. Proteomics Clin Appl. 2007. PMID: 21136768

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters